These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16731025

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB, Melvin KG, Whishaw IQ, Suchowersky O.
    Behav Brain Res; 2008 Dec 12; 194(2):207-13. PubMed ID: 18692094
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
    Montastruc JL, Celsis P, Agniel A, Demonet JF, Doyon B, Puel M, Marc-Vergnes JP, Rascol A.
    Mov Disord; 1987 Dec 12; 2(4):279-89. PubMed ID: 3509776
    [Abstract] [Full Text] [Related]

  • 46. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
    Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I, Parkinson Study Group TEMPO, PRESTO Investigators.
    J Neurol Sci; 2006 Oct 25; 248(1-2):78-83. PubMed ID: 16828804
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
    Rabey JM, Streifler M, Treves T, Korczyn AD.
    Adv Neurol; 1990 Oct 25; 53():451-5. PubMed ID: 2122652
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease.
    Nyman R, Lundgren D, Nyholm D.
    J Vasc Interv Radiol; 2009 Apr 25; 20(4):500-5. PubMed ID: 19216094
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May 25; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 56. Effect of duodenal levodopa infusion on blood pressure and sweating.
    Pursiainen V, Lyytinen J, Pekkonen E.
    Acta Neurol Scand; 2012 Oct 25; 126(4):e20-4. PubMed ID: 22329867
    [Abstract] [Full Text] [Related]

  • 57. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD, Ismail HA, Frank C.
    Can Fam Physician; 2001 Jan 25; 47():112-3. PubMed ID: 11212422
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
    Diamond SG, Markham CH.
    Adv Neurol; 1984 Jan 25; 40():537-9. PubMed ID: 6695633
    [No Abstract] [Full Text] [Related]

  • 60. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
    Isacson D, Bingefors K, Kristiansen IS, Nyholm D.
    Acta Neurol Scand; 2008 Dec 25; 118(6):379-86. PubMed ID: 18547273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.